FI884850A - Infektionsmotverkande foereningar och foerfarande foer anvaendning av dessa. - Google Patents

Infektionsmotverkande foereningar och foerfarande foer anvaendning av dessa. Download PDF

Info

Publication number
FI884850A
FI884850A FI884850A FI884850A FI884850A FI 884850 A FI884850 A FI 884850A FI 884850 A FI884850 A FI 884850A FI 884850 A FI884850 A FI 884850A FI 884850 A FI884850 A FI 884850A
Authority
FI
Finland
Prior art keywords
conditions
c2h4o
compound
present
treating
Prior art date
Application number
FI884850A
Other languages
English (en)
Finnish (fi)
Other versions
FI884850A0 (fi
Inventor
Robert L Hunter
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of FI884850A publication Critical patent/FI884850A/fi
Publication of FI884850A0 publication Critical patent/FI884850A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI884850A 1987-02-20 1988-10-20 Infektionsmotverkande foereningar och foerfarande foer anvaendning av dessa. FI884850A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1733087A 1987-02-20 1987-02-20
US15073188A 1988-02-16 1988-02-16
PCT/US1988/000510 WO1988006038A1 (fr) 1987-02-20 1988-02-19 Composes anti-infectieux et procede d'utilisation

Publications (2)

Publication Number Publication Date
FI884850A true FI884850A (fi) 1988-10-20
FI884850A0 FI884850A0 (fi) 1988-10-20

Family

ID=26689732

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884850A FI884850A0 (fi) 1987-02-20 1988-10-20 Infektionsmotverkande foereningar och foerfarande foer anvaendning av dessa.

Country Status (9)

Country Link
EP (1) EP0305470B1 (fr)
JP (1) JPH01503458A (fr)
AT (1) ATE82129T1 (fr)
AU (1) AU1396588A (fr)
CA (1) CA1314221C (fr)
DE (1) DE3875871T2 (fr)
DK (1) DK582588A (fr)
FI (1) FI884850A0 (fr)
WO (1) WO1988006038A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
HUT67762A (en) * 1991-03-19 1995-04-28 Cytrx Corp Polyoxypropylene/polyoxiethylene copolymers with improved biological activity and process for producing thereof
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
DE69428521T2 (de) * 1993-02-02 2002-05-23 Xoma Technology Ltd Arzneizusammensetzungen enthaltend ein bakterizides permeabilität erhöhendes protein und ein tensid
US6214789B1 (en) 1993-03-12 2001-04-10 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5932544A (en) * 1994-05-31 1999-08-03 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
DE10358534A1 (de) 2003-12-13 2005-07-14 Henkel Kgaa Adhäsionshemmung von Mikroorganismen durch nichtionische Tenside
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US3140232A (en) * 1962-12-19 1964-07-07 Pfizer & Co C Color stabilization of tetracycline compositions with polypropylene glycols
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
JPS5283936A (en) * 1976-01-01 1977-07-13 Ortho Pharma Corp Single herpes virus inactivating acent
DE2732929A1 (de) * 1977-07-21 1979-02-01 Bayer Ag Polyaether, verfahren zu ihrer herstellung sowie ihre verwendung als lipidabsorptionshemmer
JPS5449322A (en) * 1977-09-26 1979-04-18 Daicel Chem Ind Ltd Non-medical anti-bacterial and anti-mold agent
JPS5668616A (en) * 1979-11-08 1981-06-09 Yukio Kimura Preparation of antibiotic composition
JPS579717A (en) * 1980-06-20 1982-01-19 Nippon Shinyaku Co Ltd Germicidal composition
US4376118A (en) * 1980-10-06 1983-03-08 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung

Also Published As

Publication number Publication date
ATE82129T1 (de) 1992-11-15
AU1396588A (en) 1988-09-14
EP0305470B1 (fr) 1992-11-11
EP0305470A1 (fr) 1989-03-08
JPH01503458A (ja) 1989-11-22
CA1314221C (fr) 1993-03-09
DE3875871T2 (de) 1993-04-01
DE3875871D1 (de) 1992-12-17
WO1988006038A1 (fr) 1988-08-25
DK582588A (da) 1988-12-12
FI884850A0 (fi) 1988-10-20
DK582588D0 (da) 1988-10-19

Similar Documents

Publication Publication Date Title
FI884850A0 (fi) Infektionsmotverkande foereningar och foerfarande foer anvaendning av dessa.
Emmons et al. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case
CA2006953A1 (fr) Methodes et composes pour le traitement des interactions pathologiques hydrophobes dans les liquides biologiques
ES2151897T3 (es) Benzoxazinonas como inhibidores de la transcriptasa inversa de vih.
McDade et al. Survival of Gram-negative bacteria in the environment. I. Effect of relative humidity on surface-exposed organisms.
HUT60713A (en) Process for producing pharmaceutical compositions suitable for treating hiv infections and for producing their active ingredients
Adler et al. Development of an improved selective medium for isolation of leptospires from clinical material
FI962488A (fi) HIV:n proteaasin inhibiittoreita
KR970003054B1 (ko) 마이코플라즈마 백신
Chirino-Trejo et al. Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer (Odocoileus virginianus) with necrobacillosis
US3792161A (en) Burn ointment comprising silver sulfadiazine and collagenase
Vanhoof et al. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms
Yemul et al. Bacteriology of burns
Holton et al. Mycobacterium haemophilum infection in a patient with AIDS
Goetz et al. Effects of some antibiotics on the growth of human diploid skin fibroblasts in cell culture
Lagergård Haemophilus ducreyi: pathogenesis and protective immunity
Berger et al. Penetration of clindamycin into decubitus ulcers
Walsh et al. Rhodococcus
Swerczek Inhibition of the CEM organism by the normal flora of the reproductive tract
Bisgaard et al. Isolation of Pasteurella caballi from an infected wound on a veterinary surgeon
Dyas et al. Sources of staphylococcal wound sepsis in surgical patients
Galask et al. Amniotic fluid-induced surface ultramicrocytopathology of Escherichia coli
Pérez et al. Bacterial Flora of Foot Rot: Report of Findings in 100 Cattle
US4096245A (en) Prophylactic preparation for treating mink infection caused by Pseudomonas aeruginosa
Lowbury et al. Further trials of chemoprophylaxis for burns: The value of sulfamylon and of more frequent dressings

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: EMORY UNIVERSITY